ANALYSES OF PUBLIC POLICIES--COVERAGE OF HIV DRUGS

治疗艾滋病毒和相关机会性疾病的药物疗法 感染已成为提高生活质量的主要方法 并延长艾滋病患者的生存时间。这个 本研究的目的是描述和分析公共项目 以及影响第三方覆盖所需药物的政策 艾滋病毒携带者。这项研究的重点是：艾滋病毒/艾滋病药物援助 由《瑞安·怀特关怀法案》第二章资助的项目和艾滋病毒联盟； 由符合条件的瑞安·怀特医疗法案第一章资助的计划 大都市区；国家实施的处方药政策 医疗补助计划，重点是管理性医疗；以及州政府对 私营健康保险公司对艾滋病毒相关药物的承保范围 管理型医疗计划。该项目将确定由 州医疗补助计划(包括管理医疗政策指南)， 由CARE法案第一标题和第二标题资助的方案，以及国家 对私人医疗保险的监管，增加人们获得 艾滋病毒携带者必须采取适当的药物治疗。与低国家艾滋病人合作 服务，南卡罗来纳州的一个非营利性艾滋病服务组织， 研究将确定可用作帮助 其他州制定公共政策，以增加人们获得 艾滋病毒携带者必须接受药物治疗。

Drug therapies for the treatment of HIV and related opportunistic infections have emerged as the major method to improve the quality of life and increase the length of survival for people with HIV disease. The objectives of this research are to describe and analyze public programs and policies affecting the third-party coverage of medications needed by people with HIV. The study will focus on: HIV/AIDS drug assistance programs and HIV consortia funded by Title II of the Ryan White CARE Act; the programs funded by Title I of the Ryan White CARE Act in eligible metropolitan areas; prescription drug policies implemented by the state Medicaid programs, with a focus on managed care; and state regulation of the coverage of HIV-related medications by private health insurers and managed care plans. This project will identify any policies implemented by the state Medicaid programs (including managed care policy guidelines), the programs funded by Title I and Title II of the CARE Act, and the state regulation of private health coverage that increase the access that people with HIV have to appropriate drug therapies. Working with Lowcountry AIDS Services, a non-profit AIDS service organization in South Carolina, the study will identify innovate policies that can be used as models to assist other states develop public policies to increase the access that people with HIV have to needed drug therapies.